Literature DB >> 9822993

Reducing recidivism: medication versus psychosocial rehabilitation.

C Delaney.   

Abstract

1. Noncompliance with psychotropic medications is a primary reason for recidivism to inpatient hospitalization. It is a great contributor to the "Revolving door syndrome." 2. Psychosocial rehabilitation clubhouses can decrease inpatient hospitalization in patients with chronic mental illness. Their supportive, vocational, and educational functions are worth the investment in terms of improving quality of life and functioning skills. 3. Patients on oral psychotropic medications were more compliant in this study than those on injectable neuroleptic regimens if they attended the clubhouse program. It is presumed that the clubhouse atmosphere "normalizes" the routine of taking psychotropic medications and enhances compliance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822993     DOI: 10.3928/0279-3695-19981101-15

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  4 in total

1.  The influence of causal information on judgments of treatment efficacy.

Authors:  Jennelle E Yopchick; Nancy S Kim
Journal:  Mem Cognit       Date:  2009-01

2.  A Systematic Review of Evidence for the Clubhouse Model of Psychosocial Rehabilitation.

Authors:  Colleen McKay; Katie L Nugent; Matthew Johnsen; William W Eaton; Charles W Lidz
Journal:  Adm Policy Ment Health       Date:  2018-01

3.  Recovery at the Clubhouse: challenge, responsibility and growing into a role.

Authors:  Orsolya Reka Fekete; Eva Langeland; Torill M B Larsen; Larry Davidson; Liv Grethe Kinn
Journal:  Int J Qual Stud Health Well-being       Date:  2021-12

4.  Motivation and treatment engagement intervention trial (MotivaTe-IT): the effects of motivation feedback to clinicians on treatment engagement in patients with severe mental illness.

Authors:  Eline C Jochems; Cornelis L Mulder; Arno van Dam; Hugo J Duivenvoorden; Sylvia C M Scheffer; Willem van der Spek; Christina M van der Feltz-Cornelis
Journal:  BMC Psychiatry       Date:  2012-11-24       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.